Federal investment in RNA vaccine research has supported nearly three decades of scientific work spanning infectious diseases, cancer, and vaccine development, but recent and proposed funding cuts ...

The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.

Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.

Researchers developed an RNA-based injection that prompts muscle cells to produce a natural heart-protective hormone for weeks. The sustained signal may reduce cardiac scarring, preserve healthy ...

The findings support that all cell populations within the implant are in a post mitotic state, meaning there was no evidence ...

Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting genetic instructions from DNA and creating proteins. With the power to execute a ...

ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary ADAR-mediated Axiomer™ RNA editing technology ...

Tech billionaire investor Bill Gates was given approval to "secretly" spray synthetic RNA on food products in the United States through a company called Terrana Biosciences. One Facebook post ...

When a neuron in our body gets damaged, segments of RNA produce proteins that can help repair the injury. But in neurological disorders such as ALS and spinal muscular atrophy, or following spinal ...

< Photo 1. (From left) Professor Won Do Heo and Jihwan Yu, a Ph.D. Candidate of the Department of Biological Sciences > CRISPR-Cas13, a powerful RNA-targeting technology is gaining increasing ...